Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of MK-0524B Combination Tablet vs Coadministration
NCT00479882Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Niacin + laropiprant + simvastatin in hypercholesterolemia, mixed dyslipidemia, sponsored by Merck & Co.. Started Jun 2007; status: completed.
02
Drugs
Niacin + laropiprant + simvastatin
03
Conditions
hypercholesterolemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT00479882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479882.